Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Spyros Kolovos
Affiliation
University of Oxford
ORCID
Career Start Year
2016
Papers
28
H Index
13
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36755338
Patient-reported outcomes measures of X-linked hypophosphataemia participants: findings from a prospective cohort study in the UK.
Orphanet J Rare Dis
2023
37670496
Multinational cost-effectiveness analysis of empagliflozin for heart failure patients with ejection fraction >40.
ESC Heart Fail
2023
37577867
Cost-effectiveness of empagliflozin in heart failure patients irrespective of ejection fraction in England.
J Cardiovasc Med (Hagerstown)
2023
36502614
Erratum to "Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis" [Cancer Treat. Rev. 110 (2022) 102463].
Cancer Treat Rev
2023
36755338
Patient-reported outcomes measures of X-linked hypophosphataemia participants: findings from a prospective cohort study in the UK.
Orphanet J Rare Dis
2023
36750857
Association between outpatient follow-up and incidence of revision after knee and hip replacements: a population-based cohort study.
BMC Musculoskelet Disord
2023
37670496
Multinational cost-effectiveness analysis of empagliflozin for heart failure patients with ejection fraction >40.
ESC Heart Fail
2023
37577867
Cost-effectiveness of empagliflozin in heart failure patients irrespective of ejection fraction in England.
J Cardiovasc Med (Hagerstown)
2023
36750857
Association between outpatient follow-up and incidence of revision after knee and hip replacements: a population-based cohort study.
BMC Musculoskelet Disord
2023
36502614
Erratum to "Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis" [Cancer Treat. Rev. 110 (2022) 102463].
Cancer Treat Rev
2023
36308909
Response to 'considerations regarding a network meta-analysis of targeted therapies for BRAF mutant unresectable or metastatic melanoma'.
Cancer Treat Rev
2022
36308909
Response to 'considerations regarding a network meta-analysis of targeted therapies for BRAF mutant unresectable or metastatic melanoma'.
Cancer Treat Rev
2022
35672693
Primary care consultations and pain medicine prescriptions: a comparison between patients with and without chronic pain after total knee replacement.
BMC Musculoskelet Disord
2022
35470197
Progression of chronic pain and associated health-related quality of life and healthcare resource use over 5 years after total knee replacement: evidence from a cohort study.
BMJ Open
2022
35672693
Primary care consultations and pain medicine prescriptions: a comparison between patients with and without chronic pain after total knee replacement.
BMC Musculoskelet Disord
2022
35470197
Progression of chronic pain and associated health-related quality of life and healthcare resource use over 5 years after total knee replacement: evidence from a cohort study.
BMJ Open
2022
33411004
Hospital admissions of patients with osteogenesis imperfecta in the English NHS.
Osteoporos Int
2021
31893356
Association of sleep, screen time and physical activity with overweight and obesity in Mexico.
Eat Weight Disord
2021
33973857
Guided Internet-Based Cognitive Behavioral Therapy for Depression: Implementation Cost-Effectiveness Study.
J Med Internet Res
2021
33367863
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study.
Rheumatology (Oxford)
2021
33411004
Hospital admissions of patients with osteogenesis imperfecta in the English NHS.
Osteoporos Int
2021
34812138
Unicompartmental compared with total knee replacement for patients with multimorbidities: a cohort study using propensity score stratification and inverse probability weighting.
Health Technol Assess
2021
34812138
Unicompartmental compared with total knee replacement for patients with multimorbidities: a cohort study using propensity score stratification and inverse probability weighting.
Health Technol Assess
2021
33973857
Guided Internet-Based Cognitive Behavioral Therapy for Depression: Implementation Cost-Effectiveness Study.
J Med Internet Res
2021
31893356
Association of sleep, screen time and physical activity with overweight and obesity in Mexico.
Eat Weight Disord
2021
33367863
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study.
Rheumatology (Oxford)
2021
32131849
Five-year cost-effectiveness analysis of the European Fans in Training (EuroFIT) physical activity intervention for men versus no intervention.
Int J Behav Nutr Phys Act
2020
32131849
Five-year cost-effectiveness analysis of the European Fans in Training (EuroFIT) physical activity intervention for men versus no intervention.
Int J Behav Nutr Phys Act
2020
32864627
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study.
Lancet Rheumatol
2020
33024121
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study.
Nat Commun
2020
33277297
Infection and mortality of healthcare workers worldwide from COVID-19: a systematic review.
BMJ Glob Health
2020
33277297
Infection and mortality of healthcare workers worldwide from COVID-19: a systematic review.
BMJ Glob Health
2020
33024121
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study.
Nat Commun
2020
32864627
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study.
Lancet Rheumatol
2020
30721231
The effect of a programme to improve men's sedentary time and physical activity: The European Fans in Training (EuroFIT) randomised controlled trial.
PLoS Med
2019
30870433
Correction: The effect of a programme to improve men's sedentary time and physical activity: The European Fans in Training (EuroFIT) randomised controlled trial.
PLoS Med
2019
31223562
Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs.
J Bone Oncol
2019
30721231
The effect of a programme to improve men's sedentary time and physical activity: The European Fans in Training (EuroFIT) randomised controlled trial.
PLoS Med
2019
31223562
Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs.
J Bone Oncol
2019
30870433
Correction: The effect of a programme to improve men's sedentary time and physical activity: The European Fans in Training (EuroFIT) randomised controlled trial.
PLoS Med
2019
29329486
Cost effectiveness of guided Internet-based interventions for depression in comparison with control conditions: An individual-participant data meta-analysis.
Depress Anxiety
2018
30131318
Predicting Therapy Success and Costs for Personalized Treatment Recommendations Using Baseline Characteristics: Data-Driven Analysis.
J Med Internet Res
2018
29675748
Association between obesity and depressive symptoms in Mexican population.
Soc Psychiatry Psychiatr Epidemiol
2018
29329486
Cost effectiveness of guided Internet-based interventions for depression in comparison with control conditions: An individual-participant data meta-analysis.
Depress Anxiety
2018
30131318
Predicting Therapy Success and Costs for Personalized Treatment Recommendations Using Baseline Characteristics: Data-Driven Analysis.
J Med Internet Res
2018
29675748
Association between obesity and depressive symptoms in Mexican population.
Soc Psychiatry Psychiatr Epidemiol
2018
28013125
The effect of treatment as usual on major depressive disorder: A meta-analysis.
J Affect Disord
2017
29441493
Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review.
Pharmacoecon Open
2017
28013125
The effect of treatment as usual on major depressive disorder: A meta-analysis.
J Affect Disord
2017
28260149
Utility scores for different health states related to depression: individual participant data analysis.
Qual Life Res
2017
1 - 50 of 56
Column Actions
Search
Recommended Authors
Jeff Round
Institute of Health Economics, University of Alberta
Career Start Year
2010
Number of shared co-authors
0
Bart S Ferket
Institute for Healthcare Delivery Science, Icahn School of Medicine at Mount Sinai
Career Start Year
2010
Number of shared co-authors
0
Dalia Dawoud
Stanford University
Career Start Year
2010
Number of shared co-authors
37
Mike Paulden
School of Public Health, University of Alberta
Career Start Year
2009
Number of shared co-authors
0
Mohammad Hassan Murad
Evidence Foundation
Career Start Year
2008
Number of shared co-authors
0
Benjamin P Geisler
Massachusetts General Hospital, Harvard Medical School
Career Start Year
2008
Number of shared co-authors
0
Zhen Wang
Mayo Clinic
Career Start Year
2007
Number of shared co-authors
0
Mihail Samnaliev
Axtria Inc.
Career Start Year
2005
Number of shared co-authors
0
Nicholas Mitsakakis
Institute of Health Policy Management and Evaluation, University of Toronto
Career Start Year
2003
Number of shared co-authors
0
Nilay D Shah
Mayo Clinic
Career Start Year
2002
Number of shared co-authors
1
Melanie Calvert
Institute of Applied Health Research, University of Birmingham
Career Start Year
2000
Number of shared co-authors
0
Kim Peterson
Portland VA Healthcare System
Career Start Year
1999
Number of shared co-authors
0
Victor M Montori
Knowledge and Evaluation Research Unit in Endocrinology (KER_Endo), Mayo Clinic
Career Start Year
1998
Number of shared co-authors
0
Erik J Groessl
Herbert Wertheim School of Public Health, University of California
Career Start Year
1997
Number of shared co-authors
1
Maarten J IJzerman
Technical Medical Centre, University of Twente
Career Start Year
1997
Number of shared co-authors
0
Manuel Ridao
Instituto Aragones de Ciencias de la Salud (IIS Aragon)
Career Start Year
1997
Number of shared co-authors
0
Sarah Wordsworth
Health Economics Research Centre, University of Oxford
Career Start Year
1997
Number of shared co-authors
1
Emily Beth Devine
University of Washington
Career Start Year
1997
Number of shared co-authors
1
Christopher McCabe
Queens University Belfast
Career Start Year
1996
Number of shared co-authors
0
Todd H Wagner
Stanford University School of Medicine
Career Start Year
1996
Number of shared co-authors
0
Andrew Walker
University of California San Diego
Career Start Year
1995
Number of shared co-authors
0
George Tomlinson
University Health Network
Career Start Year
1994
Number of shared co-authors
1
Ben van Hout
University of Sheffield
Career Start Year
1993
Number of shared co-authors
0
Sally C Morton
Virginia Commonwealth University
Career Start Year
1993
Number of shared co-authors
0
Jason N Doctor
University of Southern California
Career Start Year
1992
Number of shared co-authors
2
Samprit Banerjee
Weill Cornell Medical College, Cornell University
Career Start Year
1991
Number of shared co-authors
1
Chris L Pashos
Data Sciences Institute, Takeda Pharmaceuticals International Inc.
Career Start Year
1990
Number of shared co-authors
1
Gregory E Simon
Health Research Institute, Kaiser Permanente Washington
Career Start Year
1988
Number of shared co-authors
0
John B Wong
Tufts University School of Medicine
Career Start Year
1986
Number of shared co-authors
1
Roger B Davis
Beth Israel Deaconess Medical Center
Career Start Year
1982
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Daniel Prieto-Alhambra
University of Oxford
Co-authored papers
5
Edward Burn
University of Oxford
Co-authored papers
4
Albert Prats-Uribe
University of Oxford
Co-authored papers
4
Christian Reich
OHDSI Center at The Roux Institute, Northeastern University
Co-authored papers
3
David Vizcaya
Bayer Pharmaceuticals
Co-authored papers
3
Juan M Banda
Georgia State University
Co-authored papers
3
George Hripcsak
Columbia University
Co-authored papers
3
Peter R Rijnbeek
Erasmus University Medical Center
Co-authored papers
3
Daniel R Morales
University of Dundee
Co-authored papers
3
Seng Chan You
Yonsei University College of Medicine
Co-authored papers
3
Antonella Delmestri
Co-authored papers
3
Gowtham A Rao
Janssen Pharmaceutical Research and Development LLC
Co-authored papers
3
Thamir M Alshammari
Riyadh Elm University
Co-authored papers
3
Marc A Suchard
University of California los angeles
Co-authored papers
3
Matthew Spotnitz
Columbia University Irving Medical Center
Co-authored papers
3
Azza Shoaibi
Janssen Pharmaceutical Research and Development
Co-authored papers
3
Kristine E Lynch
University of Utah Health
Co-authored papers
3
Benjamin Skov Kaas-Hansen
Copenhagen University Hospital - Rigshospitalet
Co-authored papers
3
Jennifer C E Lane
Queen Mary University of London
Co-authored papers
3
Jill Hardin
Janssen Pharmaceutical Research and Development
Co-authored papers
3
Talita Duarte-Salles
Erasmus University Medical Center
Co-authored papers
3
Maria Tereza Fernandes Abrah??o
University of Sao Paulo
Co-authored papers
3
Rupa Makadia
Janssen Pharmaceutical Research and Development
Co-authored papers
3
Patrick B Ryan
Columbia University Irving Medical Center
Co-authored papers
3
Fred Nyberg
University of Gothenburg
Co-authored papers
3
Junqing Xie
University of Oxford
Co-authored papers
2
Rae Woong Park
Ajou University Graduate School of Medicine
Co-authored papers
2
Scott L DuVall
University of Utah
Co-authored papers
2
Michael Matheny
American College of Medical Informatics, Department of Veteran Affairs, Harvard University T H Chan School of Public Health, Massachusetts Institute of Technology, The American Society for Clinical Investigation, University of Kentucky, Vanderbilt University Medical Center, Vanderbilt University Medical School
Co-authored papers
2
Laura L Hester
University of North Carolina at Chapel Hill
Co-authored papers
2
1 - 30